HomeCompareNPTX vs FCPT

NPTX vs FCPT: Dividend Comparison 2026

NPTX yields 666666.67% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPTX wins by $8.275235618773884e+34M in total portfolio value
10 years
NPTX
NPTX
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full NPTX calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NPTX vs FCPT

📍 NPTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPTXFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPTX + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPTX pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPTX
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NPTX beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPTX + FCPT for your $10,000?

NPTX: 50%FCPT: 50%
100% FCPT50/50100% NPTX
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NPTX
No analyst data
Altman Z
-84.7
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPTX buys
0
FCPT buys
0
No recent congressional trades found for NPTX or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPTXFCPT
Forward yield666666.67%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$8.275235618773884e+34M$49.1K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$5,775.28
Total dividends collected$8.275075881065991e+34M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NPTX vs FCPT ($10,000, DRIP)

YearNPTX PortfolioNPTX Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,401$700.92+$66.67MNPTX
2$415,506,651,117$415,435,306,334.37$13,064$864.84+$415506.64MNPTX
3$2,419,908,598,386,268$2,419,464,006,269,573.00$15,051$1,072.48+$2419908598.37MNPTX
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$17,442$1,337.22+$13171697643084.44MNPTX
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$20,340$1,677.08+$67004927492790120.00MNPTX
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$23,880$2,116.57+$318562277003514871808.00MNPTX
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$28,241$2,689.36+$1.415484168853553e+24MNPTX
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$33,660$3,442.07+$5.878130573362507e+27MNPTX
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$40,456$4,439.95+$2.2813793009840744e+31MNPTX
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$49,063$5,775.28+$8.275235618773884e+34MNPTX

NPTX vs FCPT: Complete Analysis 2026

NPTXStock

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.

Full NPTX Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NPTX vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPTX vs SCHDNPTX vs JEPINPTX vs ONPTX vs KONPTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.